Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAssura Regulatory News (AGR)

Share Price Information for Assura (AGR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 41.64
Bid: 41.48
Ask: 41.54
Change: 0.74 (1.81%)
Spread: 0.06 (0.145%)
Open: 42.08
High: 42.08
Low: 41.20
Prev. Close: 40.90
AGR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

2 Jul 2019 07:00

RNS Number : 1070E
Assura PLC
02 July 2019
 

2 July 2019

Assura plc

 

Trading Update

For the first quarter to 30 June 2019

 

Assura's high-quality portfolio and pipeline reinforced; GPI integration progressing well

 

Assura plc ("Assura"), the leading primary care property investor and developer, today announces its Trading Update for the first quarter to 30 June 2019.

 

Jonathan Murphy, CEO, said:

"Assura made good progress in the first quarter, further enhancing our high-quality portfolio of primary care properties. Our immediate pipeline of developments and acquisitions has never been stronger, while we disposed of 12 properties that were held for sale for cash proceeds of £17 million which was above book value.

 

"In May, we completed the purchase of primary care developer GPI and welcomed a talented new team into Assura. The acquisition boosted our immediate and extended development pipeline by an initial £92 million.

 

"We continue to source exciting opportunities to grow our portfolio and provide more of the fit-for-purpose primary care facilities that the NHS urgently needs to benefit patients and reduce pressure on the organisation.

 

"We remain confident in our outlook for the full year and in our longer-term prospects."

 

Developments and strategic acquisitions strengthen market-leading portfolio

· One development completed (Darley Dale) at a cost of £2.3 million and two moved to on site (Canterbury and St Leonards); total of 12 developments on site at the period end with a total development cost of £58 million.

· Two acquisitions completed in the period at a cost of £5.5 million.

· 12 disposals completed for £17 million cash consideration at a small premium to book value.

 

GPI acquisition expands pipeline

· Current portfolio of 554 properties.

· Immediate development pipeline of £77 million.

· Immediate acquisitions pipeline increased to £64 million, compared with £41 million at March 2019.

· Total immediate pipeline value, including on site developments, of £199 million up from £142 million at the year end.

 

Active portfolio management delivering value

· Six lease re-gears agreed on £0.3 million of rent, adding weighted average of 10 years WAULT on those properties.

· Annualised rent roll at £102.1 million post disposals.

 

Strong financial position

· As at 30 June 2019 gross debt £730 million with undrawn facilities of £230 million plus cash balance of £47.5 million.

 

 

 

ENDS

For further information, please contact:

 

Assura plc:

Jayne Cottam, CFOOrla Ball, Company SecretaryDavid Purcell, Head of Financial Reporting

 

Tel: 01925 420 660

 

Finsbury:

Gordon Simpson

James Thompson

 

Tel: 0207 251 3801

 

This announcement contains inside information as defined in Article 7 of the EU Market Abuse Regulation No 596/2014 and has been announced in accordance with the Company's obligations under Article 17 of that Regulation.

 

Notes to Editors

Assura plc, a constituent of the FTSE 250 and the EPRA* indices, is a UK REIT and long-term investor in and developer of primary care property. The company, headquartered in Warrington, works with GPs, health professionals and the NHS to create outstanding spaces for health services in our communities. At 31 March 2019, Assura's property portfolio was valued at £1,979 million.

 

Further information is available at www.assuraplc.com

 

*EPRA is a registered trademark of the European Public Real Estate Association.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTLLFLRDEILIIA
Date   Source Headline
16th Oct 20177:00 amRNSScrip Dividend Declaration
10th Oct 20177:00 amRNSAppointment of Non-Executive Director
3rd Oct 20173:01 pmRNSDirectorate Change
2nd Oct 20171:07 pmRNSNotification of Major Interests in Shares
2nd Oct 20177:00 amRNSTrading Update
25th Sep 20177:00 amRNSChief Financial Officer
21st Sep 201712:21 pmRNSScrip Calculation Price
11th Sep 20174:23 pmRNSNotification of Major Interests in Shares
8th Sep 20175:20 pmRNSPDMR Notification
7th Sep 20177:00 amRNSNotice of Dividend - Property Income Distribution
1st Sep 201711:42 amRNSTotal Voting Rights
1st Sep 201710:30 amRNSExercise of Nil Cost Options under VCP
30th Aug 20177:00 amRNSAdditional Listing
21st Aug 20171:44 pmRNSAppointment of Joint Corporate Broker
17th Aug 201712:05 pmRNSNotification of Major Interest in Shares
4th Aug 20177:00 amRNSAppointment of Chief Financial Officer
1st Aug 20177:00 amRNSTotal Voting Rights
19th Jul 20174:41 pmRNSNotification of Transactions by PDMRs
18th Jul 20172:27 pmRNSResult of AGM
18th Jul 20177:00 amRNSTrading Update
17th Jul 20177:00 amRNSScrip Dividend Declaration
3rd Jul 20179:20 amRNSCorrection of Total Voting Rights
3rd Jul 20177:00 amRNSTotal Voting Rights
22nd Jun 201711:14 amRNSScrip Calculation Price
22nd Jun 201710:14 amRNSNotification of Major Interests in Shares
22nd Jun 201710:11 amRNSNotification of Major Interests in Shares
20th Jun 20174:52 pmRNSResults of Placing
20th Jun 20177:00 amRNSProposed equity Issue of new ordinary shares
16th Jun 20174:00 pmRNSAnnual Report and Notice of AGM
16th Jun 20173:12 pmRNSNotification of Major Interests in Shares
13th Jun 20172:56 pmRNSNotification of Major Interests in Shares
8th Jun 20177:00 amRNSNotice of Dividend
5th Jun 20174:55 pmRNSNotification of transaction by PDMR
30th May 20177:00 amRNSDirector Declaration
24th May 201711:29 amRNSCorrection of Dividend Information
23rd May 20177:00 amRNSAssura Full Year Results
12th May 201711:00 amRNSNotification of Major Interests in Shares
11th May 20172:46 pmRNSNotification of Major Interests in Shares
2nd May 20177:00 amRNSTotal Voting Rights
18th Apr 20177:00 amRNSScrip Dividend Declaration
11th Apr 20174:29 pmRNSNotification of Major Interest in Shares
24th Mar 20174:15 pmRNSScrip Calculation Price
9th Mar 20177:00 amRNSNotice of Dividend
27th Feb 20177:00 amRNSAppointment of CEO
17th Feb 20173:07 pmRNSNotification of Major Interest in Shares
1st Feb 201712:54 pmRNSTotal Voting Rights
1st Feb 20177:00 amRNSTrading Update
26th Jan 20179:18 amRNSNotification of Major Interest in Shares
18th Jan 20177:00 amRNSNotification of Transaction by PDMR
16th Jan 20177:00 amRNSScrip Dividend Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.